Navigation Links
Intelligent Design Book Delivers Blow to Darwin
Date:11/17/2009

CRACKS AMAZON.COM BEST SELLER LIST IN SCIENCE

Signature in the Cell makes 2009 list of top ten best selling science books

SEATTLE, Nov. 17 /PRNewswire-USNewswire/ -- Despite Darwinists' attempts to suppress the debate over evolution, a new book about the controversial theory of intelligent design made Amazon.com's list of the year's Top 10 bestselling books in science, just as the world marks 150 years since Charles Darwin published his own theory in his landmark book On the Origin of Species.

Signature in the Cell: DNA and the Evidence for Intelligent Design (HarperOne) by Dr. Stephen C. Meyer is entering its fifth printing in as many months, and continues to sell strongly both online and in stores, according to the publisher. According to Amazon.com, books on its 2009 list of best sellers are "[r]anked according to customer orders through October. Only books published for the first time in 2009 are eligible."

"Darwin is mistakenly thought to have killed the design argument in science," said Robert Crowther, director of communications at Discovery Institute's Center for Science and Culture, which is the intelligent design research program directed by Dr. Meyer. "Now, here's a book about the science of intelligent design that shows how the design argument is being revived with powerful new arguments relevant to our culture."

By using the same method of reasoning that Darwin himself used, Dr. Meyer explains how intelligent design can be formulated as a rigorous scientific argument. In Signature in the Cell Dr. Meyer shows that the digital code imbedded in DNA points powerfully to a designing intelligence and helps unravel a mystery that Darwin did not address: how did the very first life begin?

www.discovery.org/csc

www.amazon.com

SOURCE Discovery Institute


'/>"/>
SOURCE Discovery Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept. 29
2. UK scientists developing intelligent harvesting robot to save farms up to 100,000 a year
3. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
4. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
5. Daval International Awarded Orphan Drug Designation for Motor Neurone Disease Treatment
6. AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy
7. CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves
8. Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition
9. Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
10. TCT 2009 to Feature vProtect(TM) Luminal Shield, a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical
11. AEterna Zentaris Partner, Keryx Biopharmaceuticals, Receives Orphan-Drug Designation for Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/25/2017)... ... February 25, 2017 , ... The ... in an ongoing effort to create meaningful change by increasing communication, partnerships and ... emphasis on consumers and patients’ mental health well-being. , Both organizations are dedicated ...
(Date:2/24/2017)... DIEGO , Feb. 24, 2017  Aethlon Medical, ... following note authored by its Chairman and CEO, ... at the Munich Security Conference last Saturday, Bill ... virus could kill more people than nuclear weapons. Mr. ... U.S. and U.K. intelligence agencies, that scientific terrorists have ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" ... in China, today announced its financial results for the fourth ... Quarter 2016 Financial Highlights Total sales ... RMB terms, or increased by 13.6% in USD terms to ... 2015. Gross profit increased by 13.3% to ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, ...
Breaking Biology Technology:
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... 26, 2017  Acuity Market Intelligence today released ... Digital Identity".  Acuity characterizes 2017 as a "breakout" ... adoption reflects a new understanding of the potential ... and digital identity are often perceived as threats ... , Principal of Acuity Market intelligence. "However, taken ...
(Date:1/24/2017)... 24, 2017  It sounds simple and harmless—an ... monitors vital signs and alerts parents on their ... saturation level drops. But pediatric experts argue that ... with no evidence of medical benefits, especially to ... aggressively to parents of healthy babies, promising peace ...
Breaking Biology News(10 mins):